Comparison of Cognitive Performances During a Placebo Period and an Atypical Antipsychotic Treatment Period in Schizophrenia: Critical Examination of Confounds-Reference-Cited by-同舟云学术

Comparison of Cognitive Performances During a Placebo Period and an Atypical Antipsychotic Treatment Period in Schizophrenia: Critical Examination of Confounds

Published:2003-04-22 Issue:8 Volume:28 Page:1491-1500
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol

Author:

Weickert Thomas W,Goldberg Terry E,Marenco Stefano,Bigelow Llewellyn B,Egan Michael F,Weinberger Daniel R

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/1300216.pdf

Reference58 articles.

1. Benton AL, Hamsher KD, Varney NR, Spreen O (1983). Contributions to Neuropsychological Assessment. Oxford: New York.

2. Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B et al (2002). Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 159: 1018–1028.

3. Buchanan RW, Holstein C, Breier A (1994). The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biol Psychiatry 36: 717–725.

4. Callicott JH, Mattay VS, Bertolino A, Finn K, Coppola R, Frank JA et al (1999). Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 9: 20–26.

5. Carpenter WT, Gold JM (2002). Another view of therapy for cognition in schizophrenia. Biol Psychiatry 51: 969–971.

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cognitive functions following initiation of antipsychotic medication in adolescents and adults at clinical high risk for psychosis: a naturalistic sub group analysis using the MATRICS consensus cognitive battery;Child and Adolescent Psychiatry and Mental Health;2024-05-04

2. Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial;Brain, Behavior, and Immunity;2024-01

3. Aberrant memory and delusional ideation: A pernicious partnership?;Clinical Psychology Review;2023-02

4. A systematic review of the effects of psychiatric medications on social cognition;BMC Psychiatry;2021-11-29

5. REMOVED: Antidiuretic hormone associates with the cognitive memory in small-cell lung cancer patients;Current Research in Behavioral Sciences;2021-09